Congo-Kinshasa: Epidemic Coalition Focuses on Bundibugyo Ebola Vaccine

The Bundibugyo Ebola outbreak in the DR Congo is spreading rapidly, with 1,759 confirmed cases and 600 deaths reported as of July 2026. Health officials are struggling to contain the virus, which currently lacks approved vaccines or targeted treatments.
Why it matters
The rapid spread of a rare and lethal virus without existing medical countermeasures poses a significant threat to regional stability and global health security.
The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo has been labelled the fastest-growing Ebola outbreak ever, not only among the previous Bundibugyo outbreaks. This has raised concern that response efforts are falling behind the virus. As of 10 July 2026, the DR Congo had recorded 1,759 confirmed cases and 600 deaths . Neighbouring Uganda had reported 20 cases, including two fatalities and 17 recoveries.
The Africa Centres for Disease Control and Prevention (Africa CDC) has said that efforts to contain the outbreak have made progress, but warned that rising infections continue to outpace the response.
Unlike previous Ebola outbreaks caused by the Zaire strain, the current epidemic is driven by the rare Bundibugyo virus, for which there are no approved vaccines or targeted treatments. Even so, researchers have launched the first clinical trials of potential therapies, while efforts to develop vaccines are being accelerated.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in